Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
There are no sourcing links for these claims, and the Best of 2025 badges on two different medications dont add up though some claims are verifiable
Key Takeaways Retatrutide is a once-weekly injectable triple agonist targeting GLP-1, GIP, and glucagon receptors Starting dose is typically 1 mg weekly, titrating up gradually to minimize side effects Maintenance doses range from 8 mg to 12 mg weekly based on individual response Titration is critical for balancing weight loss efficacy with tolerability Clinical trials show significant weight reduction compared to placebo Always work with a healthcare provider to determine your optimal dosing schedule Overview of Retatrutide What is Retatrutide
Thats not a care model
Potential risks include hormone imbalances, effects on blood sugar levels, and increased IGF-1 (insulin-like growth factor) levels, which may lead to other risks over time
